Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masayoshi Harigai

Showing results (1-10 of 309) with videos related to

Pageof 31
Sort By:
Clinical Calcium|April 4, 2007
[Effect of CTLA4-Ig on radiographic outcome of patients with rheumatoid arthritis]Masayoshi Harigai
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 24, 2007
[CTLA4-Ig (abatacept)]Masayoshi Harigai
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|February 1, 2005
[Involvement of CD40-CD154 interaction in immunopathogenesis of collagen diseases and its application to a novel therapeutic strategy]Masayoshi Harigai
Rheumatology (Oxford, England)|February 27, 2019
Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritisMasayoshi Harigai
Modern Rheumatology|August 1, 2017
Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: A review of the literature and current perspectiveMasayoshi Harigai
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 18, 2016
[Pulmonary comorbidity in patients with rheumatoid arthritis growing interest in association with bronchiectasis]Masayoshi Harigai
Expert Opinion on Drug Safety|March 17, 2020
The safety of baricitinib in patients with rheumatoid arthritisSuguru Honda, Masayoshi Harigai
Drugs & Aging|April 9, 2025
Management of Late-Onset Rheumatoid Arthritis with Treat-to-Target StrategyMasayoshi Harigai, Takahiko Sugihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 24, 2007
[Pneumonia, pneumocystis pneumonia]Ryuji Koike, Masayoshi Harigai
Modern Rheumatology|January 5, 2022
Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitisMasayoshi Harigai, Hideto Takada
Pageof 31

Showing results (1-10 of 309) with videos related to

Sort By:
Pageof 31
Clinical Calcium|April 4, 2007
[Effect of CTLA4-Ig on radiographic outcome of patients with rheumatoid arthritis]Masayoshi Harigai
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 24, 2007
[CTLA4-Ig (abatacept)]Masayoshi Harigai
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|February 1, 2005
[Involvement of CD40-CD154 interaction in immunopathogenesis of collagen diseases and its application to a novel therapeutic strategy]Masayoshi Harigai
Rheumatology (Oxford, England)|February 27, 2019
Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritisMasayoshi Harigai
Modern Rheumatology|August 1, 2017
Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: A review of the literature and current perspectiveMasayoshi Harigai
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 18, 2016
[Pulmonary comorbidity in patients with rheumatoid arthritis growing interest in association with bronchiectasis]Masayoshi Harigai
Expert Opinion on Drug Safety|March 17, 2020
The safety of baricitinib in patients with rheumatoid arthritisSuguru Honda, Masayoshi Harigai
Drugs & Aging|April 9, 2025
Management of Late-Onset Rheumatoid Arthritis with Treat-to-Target StrategyMasayoshi Harigai, Takahiko Sugihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 24, 2007
[Pneumonia, pneumocystis pneumonia]Ryuji Koike, Masayoshi Harigai
Modern Rheumatology|January 5, 2022
Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitisMasayoshi Harigai, Hideto Takada
Pageof 31